Inovio Pharma (INO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2018 | 06-2018 | 03-2018 | 12-2017 | 09-2017 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -64,006 | -38,990 | -32,351 | -88,206 | -66,700 |
| Depreciation Amortization | 3,823 | 2,629 | 1,357 | 3,789 | 3,220 |
| Income taxes - deferred | N/A | N/A | N/A | -150 | N/A |
| Accounts receivable | 2,091 | 3,816 | -901 | 10,080 | 9,408 |
| Other Working Capital | -3,217 | -1,179 | 16,929 | 2,896 | -5,555 |
| Other Operating Activity | 5,040 | 2,125 | 2,390 | 8,382 | 10,366 |
| Operating Cash Flow | $-56,269 | $-31,598 | $-12,575 | $-63,209 | $-49,261 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 36,979 | 22,434 | 27,957 | -95,700 | -32,997 |
| PPE Investments | -1,742 | -1,615 | -1,154 | -10,294 | -9,416 |
| Sale Of Investment | N/A | N/A | N/A | 77,163 | N/A |
| Purchase Sale Intangibles | N/A | N/A | N/A | 1,000 | N/A |
| Other Investing Activity | 0 | 0 | 0 | 1,000 | 0 |
| Investing Cash Flow | $35,237 | $20,819 | $26,804 | $-27,831 | $-42,412 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 16,643 | 2,078 | -506 | 95,690 | 95,815 |
| Financing Cash Flow | $16,643 | $2,078 | $-506 | $95,690 | $95,815 |
| Beginning Cash Position | 23,787 | 23,787 | 23,787 | 19,137 | 19,137 |
| End Cash Position | 19,398 | 15,086 | 37,509 | 23,787 | 23,278 |
| Net Cash Flow | $-4,389 | $-8,701 | $13,722 | $4,650 | $4,142 |
| Free Cash Flow | |||||
| Operating Cash Flow | -56,269 | -31,598 | -12,575 | -63,209 | -49,261 |
| Capital Expenditure | -1,742 | -1,615 | -1,154 | -10,294 | -9,416 |
| Free Cash Flow | -58,011 | -33,213 | -13,729 | -73,503 | -58,676 |